Vaccinex Inc (VCNX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,634 | -20,251 | -19,815 | -22,380 | -28,851 |
| Depreciation Amortization | 94 | 119 | 207 | 169 | 307 |
| Accounts receivable | 123 | -786 | -175 | 157 | 741 |
| Accounts payable and accrued liabilities | 1,914 | 521 | 457 | -2,108 | 122 |
| Other Working Capital | 2,103 | 318 | -11 | -3,210 | -1,067 |
| Other Operating Activity | -1,786 | -1,300 | 263 | 2,074 | 101 |
| Operating Cash Flow | $-16,186 | $-21,379 | $-19,074 | $-25,298 | $-28,647 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -22 | -67 | -99 | -32 | -290 |
| Investing Cash Flow | $-22 | $-67 | $-99 | $-32 | $-290 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 8,000 |
| Debt Issued | N/A | N/A | N/A | N/A | 1,134 |
| Debt Repayment | -76 | -74 | -75 | -9 | N/A |
| Common Stock Issued | 14,159 | 16,664 | 17,050 | 32,848 | 28,494 |
| Other Financing Activity | 1,697 | 0 | 0 | -9,516 | -871 |
| Financing Cash Flow | $15,780 | $16,590 | $16,975 | $23,323 | $36,757 |
| Beginning Cash Position | 1,535 | 6,391 | 8,589 | 10,596 | 2,776 |
| End Cash Position | 1,107 | 1,535 | 6,391 | 8,589 | 10,596 |
| Net Cash Flow | $-428 | $-4,856 | $-2,198 | $-2,007 | $7,820 |
| Free Cash Flow | |||||
| Operating Cash Flow | -16,186 | -21,379 | -19,074 | -25,298 | -28,647 |
| Capital Expenditure | -22 | -67 | -99 | -32 | -290 |
| Free Cash Flow | -16,208 | -21,446 | -19,173 | -25,330 | -28,937 |